Search - tctmd.com

Displaying 381 - 400 of 637

Sort: Relevancy | Date

News Daily News

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

Todd Neale

September 19, 2017

News Opinion Fellow Talk

Physical Fitness for Fellows: Better Late Than Never

Bhuvnesh Aggarwal, MD

August 18, 2017

News Daily News

Break to Fix? Purposely Fracturing Failed Surgical Valves May Help Transcatheter ViV Delivery

Caitlin E. Cox

July 18, 2017

News Daily News

ECGs Ordered After One in Five Annual Health Exams

Shelley Wood

July 13, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Caitlin E. Cox

June 14, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

News Conference News SCAI 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

L.A. McKeown

May 15, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Conference News SCAI 2017

Domo Arigato: High Success Rates, Low Radiation With Both Radial and Femoral Robotic PCI

L.A. McKeown

May 12, 2017

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Shelley Wood

May 05, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News

Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes

Michael O'Riordan

April 13, 2017

News Daily News

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

Todd Neale

April 05, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Opinion Conversations in Cardiology

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

February 27, 2017

News Featured Fellow

Matthew Feinstein, MD

Yael L. Maxwell

February 24, 2017

Advertisement

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

Physical Fitness for Fellows: Better Late Than Never

Break to Fix? Purposely Fracturing Failed Surgical Valves May Help Transcatheter ViV Delivery

ECGs Ordered After One in Five Annual Health Exams

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Bioresorbable Scaffolds: Where Do We Go From Here?

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Domo Arigato: High Success Rates, Low Radiation With Both Radial and Femoral Robotic PCI

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

Matthew Feinstein, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content